Adolfo Gonzalez will never forget the day his 2-year-old son was born. "It was incredible. It was the best feeling ever," said Gonzalez. The excitement turned to devastation one year later when a ...
How to cure Juvenile Myelomonocytic Leukemia: The most effective treatment for JMML is an allogeneic hematopoietic stem cell transplant, better known as a bone marrow transplant (BMT), say experts ...
– Results highlight PPMP as a tool for identifying most promising drug combinations for patients in high unmet medical needs, including JMML – JMML is a rare, aggressive pediatric malignancy for which ...
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML) enrolled in a phase II ...
The patient presented at age 6 months with hepatosplenomegally, thrombocytopenia, and GI bleeding. Initial WBC was 42.8 × 10 9 /l and marrow assessment showed JMML (based on the International JMML ...
Researchers have discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or ...
Juvenile myelomonocytic leukemia (JMML) is a rare but aggressive childhood leukemia. While hematopoietic stem cell transplantation is curative for some patients, approximately half of all patients see ...
Indiana University School of Medicine researchers have identified a promising new combination of drugs to treat juvenile myelomonocytic leukemia (JMML), a rare form of blood cancer that affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results